| 國立成功大學 |
2024-11-14 |
β-d-Ribofuranose as a Core with a Phosphodiester Moiety as the Enzyme Recognition Site for Codrug Development
|
Hwu;Ru, Jih;Panja;Avijit;Tsay;Shwu-Chen;Huang;Wen-Chieh;Lin;Shu-Yu;Yeh;Chen-Sheng;Su;Wu-Chou;Yang;Li-Xing;Shieh;Dar-Bin |
| 國立成功大學 |
2024-09 |
A rare case of an endobronchial mass due to Neurospora intermedia
|
Wu;Wan-Lin;Lee;Jen-Chieh;Su;Wu-Chou;Wang;Sheng-Yuan;Wu;Chi-Jung |
| 國立成功大學 |
2024-09 |
Registry of Genetic Alterations of Taiwan Non-Small Cell Lung Cancer by Comprehensive Next-Generation Sequencing: A Real-World Cohort Study-Taiwan Cooperative Oncology Group T1521
|
Liao;Bin-Chi;Chiang;Nai-Jung;Chang;Gee-Chen;Su;Wu-Chou;Luo;Yung-Hung;Chong;Inn-Wen;Yang;Tsung-Ying;Lai;Chun-Liang;Hsia;Te-Chun;Ho;Ching-Liang;Lee;Kang-Yun;Hsiao;Chin-Fu;Ku;Fan-Chen;Fang;Wei-Tse;Yang;James, Chih-Hsin |
| 國立成功大學 |
2024-08-13 |
Erdafitinib in Asian patients with advanced solid tumors: an open-label, single-arm, phase IIa trial
|
Park;Oh, Joon;Feng;Yin-Hsun;Su;Wu-Chou;Oh;Do-Youn;Keam;Bhumsuk;Shen;Lin;Kim;Sang-We;Liu;Xiufeng;Liao;Huimin;Qing;Min;Zhang;Chong;Qian;Jiaqi;Tang;Xiaodan;Li;Peng;Triantos;Spyros;Sweiti;Hussein |
| 國立成功大學 |
2024-07-25 |
Pembrolizumab with platinum-based chemotherapy with or without epacadostat as first-line treatment for metastatic non-small cell lung cancer: a randomized, partially double-blind, placebo-controlled phase II study
|
Boyer;Michael;Hui;Rina;Urban;Damien;Clingan;Philip;Su;Wu-Chou;Devaux;Celine;Gadgeel;Shirish;Garassino;Marina;Leopold;Lance;Daniel;Jeannie;Munteanu;Mihaela, C.;Samkari;Ayman;Luo;Yiwen;Abreu;Rodriguez, Delvys |
| 國立成功大學 |
2024-06-1 |
Datopotamab deruxtecan (Dato-DXd) plus pembrolizumab (pembro) with or without platinum chemotherapy (Pt-CT) as first-line (1L) therapy for advanced non-small cell lung cancer (aNSCLC): Subgroup analysis from TROPION-Lung02
|
Levy;Philip, Benjamin;Paz-Ares;Luis, G.;Su;Wu-Chou;Herbert;Scott, M.;Yang;Tsung-Ying;Tolcher;Anthony, W.;Lou;Yanyan;Zenke;Yoshitaka;Cortinovis;Luigi, Diego;Felip;Enriqueta;Domine;Manuel;Sr;Leventakos;Konstantinos;Calvo;Emiliano;Horiike;Atsushi;Pan;Edward;Lin;Daisy;Jia;Xiaoyu;Basak;Priyanka;Chisamore;Jon, Michael;Goto;Yasushi |
| 國立成功大學 |
2024-06-1 |
Intracranial efficacy of datopotamab deruxtecan (Dato-DXd) in patients (pts) with previously treated advanced/metastatic non-small cell lung cancer (a/m NSCLC) with actionable genomic alterations (AGA): Results from TROPION-Lung05
|
Lisberg;Aaron;Ahn;Myung-Ju;Kitazono;Satoru;Cho;Chul, Byoung;Blumenschein;George, R.;Shum;Elaine;Pons-Tostivint;Elvire;Goto;Yasushi;Yoh;Kiyotaka;Paz-Ares;Luis, G.;Heist;Suk, Rebecca;Baas;Paul;Planchard;David;Perol;Maurice;Felip;Enriqueta;Su;Wu-Chou;Zebger-Gong;Hong;Lan;Lan;Liu;Chelsea;Sands;Jacob |
| 國立成功大學 |
2024-06-01 |
Efficacy and safety of erdafitinib in patients with advanced or metastatic cholangiocarcinoma and FGFR alterations: Pooled analysis of RAGNAR and LUC2001 studies.
|
Pant;Shubham;Park;Oh, Joon;Su;Wu-Chou;Schuler;Martin, H.;Loriot;Yohann;Iyer;Gopa;Doi;Toshihiko;Qin;Shukui;Tabernero;Josep;Prenen;Hans;Folprecht;Gunnar;Winter;Helen;Molin, Dal;Zibetti, Graziela;Sweiti;Hussein;Najmi;Saltanat;Hammond;Constance;Liao;Huimin;Thomas;Shibu;Triantos;Spyros;Feng;Yin-Hsun |
| 國立成功大學 |
2024-05-22 |
IL-33/NF-κB/ST2L/Rab37 positive-feedback loop promotes M2 macrophage to limit chemotherapeutic efficacy in lung cancer
|
Yang;You-En;Hu;Meng-Hsuan;Zeng;Yen-Chen;Tseng;Yau-Lin;Chen;Ying-Yung;Su;Wu-Chou;Chang;Chih-Peng;Wang;Yi-Ching |
| 國立成功大學 |
2024-02-07 |
Rab37 mediates trafficking and membrane presentation of PD-1 to sustain T cell exhaustion in lung cancer
|
Kuo;Wan-Ting;Kuo;I-Ying;Hsieh;Hung-Chia;Wu;Ssu-Ting;Su;Wu-Chou;Wang;Yi-Ching |
